other material
confidence high
sentiment negative
materiality 0.65
PAVmed stockholders approve 4x increase in authorized shares to 250M and Series C Preferred issuance
PAVmed Inc.
- Stockholders approved amending the certificate of incorporation to increase authorized common shares from 50M to 250M, effective Jan 15, 2025.
- Stockholders also approved the issuance of common stock upon conversion of Series C Convertible Preferred shares.
- Series C Preferred will be issued under a Debt Exchange Agreement and a Securities Purchase Agreement, both dated November 2024.
- Company expects to consummate the Series C Preferred issuance and debt exchange by January 31, 2025.
- Vote tallies: For amendment 5.23M vs 0.72M against; for issuance 5.48M vs 0.46M against.